DOI:10.1016/j.contraception.2023.109978 - Corpus ID: 257068251
A commentary on progestin-only pills (POPs) and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.
@article{Wollum2023ACO, title={A commentary on progestin-only pills (POPs) and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.}, author={Alexandra Wollum and Carmela Zuniga and Kelly Blanchard and Stephanie B. Teal}, journal={Contraception}, year={2023}, pages={ 109978 }, url={https://api.semanticscholar.org/CorpusID:257068251}}- A. WollumC. ZunigaS. Teal
- Published inContraception1 February 2023
- Medicine
8 Citations
8 Citations
Opill
- Rebecca H. AllenDeborah Bartz
- 2023
Medicine
The recent approval of progestin-only norgestrel for over-the-counter use has the potential to expand access to contraception nationwide and improve the accessibility of effective contraception for many pregnancy-capable Americans, especially those who have poor access to the health care system for prescription-required contraception.
Over-the-counter access to hormonal contraception: a global perspective
Over-the-counter availability has the potential to increase access to safe and effective contraception in the United States, United Kingdom, and other countries where a prescription is currently required and is associated with relatively high user satisfaction.
Over-the-counter access to combined oral contraceptives for individuals with hypertension: an expert review
- K. GrindlayKatherine KeyDaniel Grossman
- 2025
Medicine
Provider Perceptions of Over-the-Counter Progestin-Only Birth Control Pills in Urban, Suburban, and Rural Populations of Pennsylvania
- Schyler SaidSarah WaszynKatelyn D LeXuezhi Jiang
- 2025
Medicine, Sociology
There is a notable lack of awareness and clinical training of the Opill within Pennsylvania's urban, suburban, and rural providers, and providers may be less likely to support and recommend Opill to patients as opposed to other oral contraceptives.
Efficacy and safety of drospirenone as a progestin‐only pill in Japanese women: A phase III study
- Kunio KitamuraEnrico ColliRyoko KikuyamaYumiko KuriharaRieko AzumaTomoya Kagawa
- 2025
Medicine
The journal of obstetrics and gynaecology…
To evaluate the efficacy and safety of 4 mg of drospirenone (DRSP), a progestin‐only pill (POP), for contraception in Japanese women.
New Options in Contraception
- Konia Trouton
- 2024
Medicine
Canadian Women's Health Today
Changes to insurance coverage for contraception, such as provincial coverage for some (British Columbia, Quebec and Manitoba), and private insurance offered through school or an employer, are introduced into Canada, expanding choice for patients.
31 References
The effect of deliberate non-adherence to a norgestrel progestin-only pill: a randomized, crossover study.
- A. GlasierA. EdelmanAgnes Hemon
- 2022
Medicine
A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen
- I. DuijkersD. Heger-MahnD. DrouinS. Skouby
- 2015
Medicine
The new drospirenone-only pill inhibited ovulation as effectively as the desogestrel- only pill despite the 4-day hormone-free interval.
Progestin-only pills for contraception.
- D. GrimesL. LopezP. O'BrienE. Raymond
- 2010
Medicine
Evidence is insufficient to compare progestin-only pills to each other or to combined oral contraceptives, but high losses to follow up undermined the trial.
Effects of progestin-only contraceptives on the endometrium
Progestin-only contraception provides a safe and effective control of fertility regulation, although, they are associated with the problem of endometrial break through bleeding that may lead to discontinuation, making mandatory a deeper understanding of the mechanisms involved.
The clinical relevance of progestogens in hormonal contraception: Present status and future developments
- P. Regidor
- 2018
Medicine
Progestogens can be derived from testosterone, progesterone, and spironolactone that determine pharmacodynamic and pharmacokinetic differential effects that contribute to the tolerability and additional beneficial or therapeutic effects whether used in combined oral contraceptives COC or as progestogen only drugs enhancing the individual options for different patient profiles.
Related Papers
Showing 1 through 3 of 0 Related Papers